Engin KÖSE, Melis KÖSE, Zeynep AKIŞIN, Selvinaz EDİZER, Ferah GENEL, Zehra Burcu YILMAZ, Ahmet ŞAHİN

Different clinical presentation in a patient with two novel pathogenic variants of the FBXL4 gene

Background. The recently described FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome 13 (MTDPS13) manifests with severe encephalopathy, early-onset lactic acidosis, hypotonia, developmental delay and feeding difficulty. Less than 100 cases with FBXL4-related MTDPS13 and 47 pathogenic mutations in the FBXL4 gene have been identified thus far. Here, we describe a patient diagnosed with MTDPS13 with two novel variants of the FBXL4 gene. Case. A 51-day-old male was admitted with the complaint of bloody stool. His physical examination revealed facial dysmorphic features, developmental delay and truncal hypotonia with lack of head control. Laboratory investigations showed anemia, neutropenia, metabolic acidosis with hyperlactatemia, elevated fumaric acid, 2-ketoglutaric acid in urine and elevated alanine level in plasma which were consistent with mitochondrial dysfunction. Brain magnetic resonance imaging (MRI) showed large ventricles, thin corpus callosum and poor myelination. Drug-resistant epilepsy developed during the clinical follow-up. Ketogenic diet was initiated for intractable epilepsy; which was then interrupted due to severe metabolic acidosis. Compound heterozygous pathogenic variants were detected in the FBXL4 gene [p.Gly258* (c.772G>T, Exon 5)/p.Trp354Ser (c.1061G>C, Exon 6)] with whole-exome sequencing. Conclusion. We detected two novel variants of the FBXL4 gene. To the best of our knowledge, this is the first case in the literature that presented with gastrointestinal bleeding as an encephalomyopathic form of mitochondrial DNA depletion syndromes and for whom ketogenic diet was initiated due to intractable epilepsy, which was not reported in previous cases.

PDF

___

1. Bonnen PE, Yarham JW, Besse A, et al. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. Am J Hum Genet 2013; 93: 471-481.
2. Almannai M, Dai H, El-Hattab AW, Wong LJC. FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle, 2017. Available from http://www.ncbi.nlm.nih.gov/books/ NBK425540/.
3. Dai H, Zhang VW, El-Hattab AW, et al. FBXL4 defects are common in patients with congenital lactic acidemia and encephalomyopathic mitochondrial DNA depletion syndrome. Clin Genet 2017; 91: 634- 639.
4. El-Hattab AW, Dai H, Almannai M, et al. Molecular and clinical spectra of FBXL4 deficiency. Hum Mutat 2017; 38: 1649-1659.
5. Ballout RA, Al Alam C, Bonnen PE, Huemer M, ElHattab AW, Shbarou R. FBXL4-related mitochondrial DNA depletion syndrome 13 (MTDPS13): a case report with a comprehensive mutation review. Front Genet 2019; 10: 39.
6. Shamseldin HE, Alshammari M, Al-Sheddi T, et al. Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes. J Med Genet 2012; 49: 234-241.
7. Antoun G, McBride S, Vanstone JR, et al. Detailed biochemical and bioenergetic characterization of FBXL4-related encephalomyopathic mitochondrial DNA depletion. JIMD Rep 2016; 27: 1-9.
8. Fukuyama K, Ishikawa Y, Ogino T, et al. Mucosal necrosis of the small intestine in myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome. World J Gastroenterol 2012; 18: 5986-5989.
9. Barøy T, Pedurupillay CR, Bliksrud YT, et al. A novel mutation in FBXL4 in a Norwegian child with encephalomyopathic mitochondrial DNA depletion syndrome 13. Eur J Med Genet 2016; 59: 342-346.
10. Huemer M, Karall D, Schossig A, et al. Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations. J Inherit Metab Dis 2015; 38: 905-914.
11. Gai X, Ghezzi D, Johnson MA, et al. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. Am J Hum Genet 2013; 93: 482-495.